Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Cladistics : the International Journal of the Willi Hennig Society
|
November 13, 2021
Molecular phylogeny of Indo-Pacific carpenter ants (Hymenoptera: Formicidae, Camponotus) reveals waves of dispersal and colonization from diverse source areas
Ronald M Clouse, Milan Janda, Benjamin Blanchard, et al.
Plos Pathogens
|
April 9, 2021
Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2
Huihui Mou, Brian D Quinlan, Haiyong Peng, et al.
Journal of Virology
|
March 30, 2012
A nonfucosylated variant of the anti-HIV-1 monoclonal antibody b12 has enhanced FcγRIIIa-mediated antiviral activity in vitro but does not improve protection against mucosal SHIV challenge in macaques
Brian Moldt, Mami Shibata-Koyama, Eva G Rakasz, et al.
Molecular Therapy. Advances
|
May 15, 2026
<i>In vivo</i> HSC gene therapy enables sustained eCD4-Ig expression for SIV prevention
Chang Li, Anna K Anderson, Anne-Sophie Kuhlmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 20, 2014
Live simian immunodeficiency virus vaccine correlate of protection: local antibody production and concentration on the path of virus entry
Qingsheng Li, Ming Zeng, Lijie Duan, et al.
Journal of Virology
|
August 17, 2012
Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family
Mattia Bonsignori, Justin Pollara, M Anthony Moody, et al.
Science Translational Medicine
|
March 21, 2014
Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination
Nicole L Yates, Hua-Xin Liao, Youyi Fong, et al.
The Journal of Clinical Investigation
|
August 9, 2014
FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial
Shuying S Li, Peter B Gilbert, Georgia D Tomaras, et al.
Nature
|
February 25, 2015
AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges
Matthew R Gardner, Lisa M Kattenhorn, Hema R Kondur, et al.
The New England Journal of Medicine
|
April 6, 2012
Immune-correlates analysis of an HIV-1 vaccine efficacy trial
Barton F Haynes, Peter B Gilbert, M Juliana McElrath, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Cladistics : the International Journal of the Willi Hennig Society
|
November 13, 2021
Molecular phylogeny of Indo-Pacific carpenter ants (Hymenoptera: Formicidae, Camponotus) reveals waves of dispersal and colonization from diverse source areas
Ronald M Clouse, Milan Janda, Benjamin Blanchard, et al.
Plos Pathogens
|
April 9, 2021
Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2
Huihui Mou, Brian D Quinlan, Haiyong Peng, et al.
Journal of Virology
|
March 30, 2012
A nonfucosylated variant of the anti-HIV-1 monoclonal antibody b12 has enhanced FcγRIIIa-mediated antiviral activity in vitro but does not improve protection against mucosal SHIV challenge in macaques
Brian Moldt, Mami Shibata-Koyama, Eva G Rakasz, et al.
Molecular Therapy. Advances
|
May 15, 2026
<i>In vivo</i> HSC gene therapy enables sustained eCD4-Ig expression for SIV prevention
Chang Li, Anna K Anderson, Anne-Sophie Kuhlmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 20, 2014
Live simian immunodeficiency virus vaccine correlate of protection: local antibody production and concentration on the path of virus entry
Qingsheng Li, Ming Zeng, Lijie Duan, et al.
Journal of Virology
|
August 17, 2012
Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family
Mattia Bonsignori, Justin Pollara, M Anthony Moody, et al.
Science Translational Medicine
|
March 21, 2014
Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination
Nicole L Yates, Hua-Xin Liao, Youyi Fong, et al.
The Journal of Clinical Investigation
|
August 9, 2014
FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial
Shuying S Li, Peter B Gilbert, Georgia D Tomaras, et al.
Nature
|
February 25, 2015
AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges
Matthew R Gardner, Lisa M Kattenhorn, Hema R Kondur, et al.
The New England Journal of Medicine
|
April 6, 2012
Immune-correlates analysis of an HIV-1 vaccine efficacy trial
Barton F Haynes, Peter B Gilbert, M Juliana McElrath, et al.
Page
of 6